Skip to main content

NFL BIOSCIENCES: ANALYST COVERAGE LAUNCHED WITH INVEST SECURITIES

NFL BIOSCIENCES: ANALYST COVERAGE LAUNCHED WITH INVEST SECURITIES

  • Recommendation: BUY
  • Target share price: €4.90

NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), a biopharmaceutical company developing botanical drugs for the treatment of addictions, is today announcing the start of NFL Biosciences’ analyst coverage by Invest Securities, an independent financial services provider whose research activities are carried out by 12 professionals covering more than 120 companies in diverse sectors.

The coverage of NFL Biosciences follows the research agreement set up after its initial public offering on Euronext Growth Paris in June 2021. This analysis was carried out by Thibaut Voglimacci Stephanopoli, a specialist Health and MedTech stock analyst.

Available on NFL Biosciences’ website (“Investors” section), the analysis recommends buying the NFL Biosciences share, with a target share price of €4.90.

Closing share price prior to publication: €3.59

About de NFL Biosciences
NFL Biosciences is a biopharmaceutical company based in Montpellier, France, whose most advanced botanical drug candidate is an aid to stop smoking. Known as NFL-101, this natural nicotine-free product, extracted from standard tobacco leaves, is protected by two patent families. NFL Biosciences aims to offer smokers who would like to stop a safe, natural solution that is effective over the long-term, with short-term personalized administration.
Alongside NFL-101, NFL Biosciences has various development projects focused on botanical drugs for the treatment of cannabis use disorder and alcoholism.
Learn more at http://www.nflbiosciences.com

NFL Biosciences’ shares are listed on Euronext Growth Paris. (FR0014003XT0 ALNFL)
Contacts
Bruno Lafont – info@nflbiosciences.com – +33 (0)4 11 93 76 67
Agence Calyptus – nflbio@calyptus.net – +33 (0)1 53 65 68 68

Attachment

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.